Drug-related pulmonary problems in patients with rheumatoid arthritis-Reference-Cited by-同舟云学术

Drug-related pulmonary problems in patients with rheumatoid arthritis

Published:2006-03-09 Issue:7 Volume:45 Page:787-789
ISSN:1462-0332
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Saravanan V.,Kelly C.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/45/7/787/9448496/kel075.pdf

Reference26 articles.

1. Committee on Safety of Medicines. Methotrexate and pneumonitis: new recommendations on monitoring for pulmonary symptoms. Curr Probl Pharmacovigilance2003;29:5.

2. National Patient Safety Agency. Methotrexate: patient information leaflet. London: NPSA,2004.

3. Ito S, Sumida T. Interstitial lung disease associated with leflunomide. Intern Med2004;43:1103–4.

4. Kamata Y, Nara H, Kamimura T et al. Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction. Intern Med2004;43:1201–4.

5. McCurry J. Japan deaths spark concerns over arthritis drug. Lancet2004;363:461.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diffuse lung involvement in rheumatoid arthritis: a respiratory physician's perspective;Chinese Medical Journal;2023-01-19

2. Research Progress of Rheumatoid Arthritis Combined with Lung Interstitial Disease;Advances in Clinical Medicine;2023

3. Dermatomyositis;Interdisciplinary Approaches to Overlap Disorders in Dermatology & Rheumatology;2022

4. Lung Injury Induced by Antitumor Drugs: Prevalence, Certain Drugs and Their Mechanisms of Action. Part 2;Tuberculosis and Lung Diseases;2021-09-10

5. High rates of therapeutic changes in patients with psoriatic arthritis receiving treatment with disease-modifying antirheumatic drugs: A cross-sectional study;Modern Rheumatology;2021-08-26